Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
Henlius' adalimumab biosimilar HANDAYUAN wins first overseas approval in Pakistan
Dealroom.co1 min read
Henlius' adalimumab biosimilar HANDAYUAN wins first overseas approval in Pakistan Dealroom
Read the full article at Dealroom.coRelated coverage
Stock Market Today Highlights, Sept 2: Sensex ends 373 pts lower at 76, 570, Nifty below 24, 000; Asian Paints, HDFC Bank fall most
thehindubusinessline.com · Sep 2, 2026
Links #5: 2026/07
LessWrong · Jul 31, 2026
AI Policy
Hegseth AutoWarCom: who builds it, what the money buys, and why its hardest problem after Minab is the record, not the model
livetradingnews.com · Oct 2, 2026
The People of Utah vs. Kevin O’Leary
The Verge · Oct 1, 2026